Exact Mass: 532.0637638
Exact Mass Matches: 532.0637638
Found 58 metabolites which its exact mass value is equals to given mass value 532.0637638
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
cefsulodin
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams A pyridinium-substituted semi-synthetic, broad-spectrum, cephalosporin antibiotic. C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic Same as: D07653
dTDP-4-dehydro-alpha-D-xylose
cefsulodin
Cfda-AM
(5aS,6S)-2-Methyl-1,3,4-trioxo-1,2,3,4,5a,6-hexahydrooxepino[3,4:4,5]pyrrolo[1,2-a]pyrazin-6-yl 3-(5-formyl-2-hydroxyphenoxy)-4-methoxybenzoate
[(5aS,6S)-2-methyl-1,3,4-trioxo-5a,6-dihydrooxepino[1,2]pyrrolo[4,5-c]pyrazin-6-yl] 3-(5-formyl-2-hydroxyphenoxy)-4-methoxybenzoate
[(5aS,6S)-2-methyl-1,3,4-trioxo-5a,6-dihydrooxepino[1,2]pyrrolo[4,5-c]pyrazin-6-yl] 3-(5-formyl-2-hydroxyphenoxy)-4-methoxybenzoate [IIN-based on: CCMSLIB00000848815]
[(5aS,6S)-2-methyl-1,3,4-trioxo-5a,6-dihydrooxepino[1,2]pyrrolo[4,5-c]pyrazin-6-yl] 3-(5-formyl-2-hydroxyphenoxy)-4-methoxybenzoate [IIN-based: Match]
N-[2-[(2-bromo-4,6-dinitrophenyl)azo]-5-(diallylamino)-4-methoxyphenyl]acetamide
C21H21BrN6O6 (532.0705866000001)
2-(Perfluorooctyl)ethyl methacrylate
C14H9F17O2 (532.0331057999999)
[(2R,5R)-3-acetyloxy-5-[[6-(4-chlorophenyl)sulfanyl-5-cyanopyridine-3-carbonyl]carbamoylamino]oxolan-2-yl]methyl acetate
[hydroxy-[(2R,4R,5S)-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxyphosphoryl] [(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl hydrogen phosphate
[(2R,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl] [hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] hydrogen phosphate
2-(2-chlorophenyl)-N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-4-quinolinecarboxamide
C27H21ClN4O4S (532.0971976000001)
methyl N-(2,6-dichlorobenzyl)-3-[2-(2,6-dichlorophenyl)-6-quinolyl]alaninate
C26H20Cl4N2O2 (532.0278820000001)
N-(2,6-dichlorobenzyl)-3-[2-(2,6-dichlorophenyl)-6-quinolyl]-N-methylalanine
C26H20Cl4N2O2 (532.0278820000001)
An alanine derivative that is alanine substituted by a methyl and a 2,6-dichlorobenzyl group at N and a 2-(2,6-dichlorophenyl)-6-quinolyl group at position 3.
[4-[(E)-3-hydroxy-3-[2,4,6-trihydroxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]prop-1-enyl]phenyl] hydrogen sulate
(1s,14r)-4,9,19-trihydroxy-11,17-dimethyl-3,7,15,21-tetraoxo-6,22-dioxaheptacyclo[12.9.1.1¹,¹⁶.1⁴,⁸.0²,¹³.0¹²,²⁶.0²⁰,²⁵]hexacosa-2(13),8(26),9,11,16,18,20(25)-heptaen-24-yl acetate
(3,4-dihydroxy-6-methyloxan-2-yl)oxy([hydroxy([(2r,3r)-3-hydroxy-5-(4-hydroxy-5-methyl-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy)phosphoryl]oxy)phosphinic acid
5-methyl-3,4,6-trioxo-11-oxa-2,5-diazatricyclo[7.5.0.0²,⁷]tetradeca-7,9,12-trien-14-yl 3-(5-formyl-2-hydroxyphenoxy)-4-methoxybenzoate
[(4s,5r,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy([hydroxy([(2r,3s,5r)-3-hydroxy-5-(4-hydroxy-5-methyl-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy)phosphoryl]oxy)phosphinic acid
5,6,8-trihydroxy-2-methyl-9-[(2s)-5,6,8-trihydroxy-2-(hydroxymethyl)-4-oxo-2h,3h-naphtho[2,3-b]pyran-9-yl]benzo[g]chromen-4-one
(1r,4s,5r,7s,8s,12r,15s,16r,18s,19s)-19-(acetyloxy)-2,13-dioxo-6,17-dioxa-23,24-dithia-3,14-diazaoctacyclo[10.10.2.0¹,¹⁴.0³,¹².0⁴,¹⁰.0⁵,⁷.0¹⁵,²¹.0¹⁶,¹⁸]tetracosa-9,20-dien-8-yl butanoate
5,6,8-trihydroxy-2-methyl-9-[5,6,8-trihydroxy-2-(hydroxymethyl)-4-oxo-2h,3h-naphtho[2,3-b]pyran-9-yl]benzo[g]chromen-4-one
(1s,14s)-5-methyl-3,4,6-trioxo-11-oxa-2,5-diazatricyclo[7.5.0.0²,⁷]tetradeca-7,9,12-trien-14-yl 3-(5-formyl-2-hydroxyphenoxy)-4-methoxybenzoate
5,6,8-trihydroxy-2-methyl-9-[5,6,8-trihydroxy-2-(hydroxymethyl)-4-oxobenzo[g]chromen-9-yl]-2h,3h-naphtho[2,3-b]pyran-4-one
(1s,4s,14r,24s)-4,9,19-trihydroxy-11,17-dimethyl-3,7,15,21-tetraoxo-6,22-dioxaheptacyclo[12.9.1.1¹,¹⁶.1⁴,⁸.0²,¹³.0¹²,²⁶.0²⁰,²⁵]hexacosa-2(13),8(26),9,11,16,18,20(25)-heptaen-24-yl acetate
4,9,19-trihydroxy-11,17-dimethyl-3,7,15,21-tetraoxo-6,22-dioxaheptacyclo[12.9.1.1¹,¹⁶.1⁴,⁸.0²,¹³.0¹²,²⁶.0²⁰,²⁵]hexacosa-2(13),8(26),9,11,16,18,20(25)-heptaen-24-yl acetate
19-(acetyloxy)-2,13-dioxo-6,17-dioxa-23,24-dithia-3,14-diazaoctacyclo[10.10.2.0¹,¹⁴.0³,¹².0⁴,¹⁰.0⁵,⁷.0¹⁵,²¹.0¹⁶,¹⁸]tetracosa-9,20-dien-8-yl butanoate
(2r)-5,6,8-trihydroxy-2-methyl-9-[5,6,8-trihydroxy-2-(hydroxymethyl)-4-oxobenzo[g]chromen-9-yl]-2h,3h-naphtho[2,3-b]pyran-4-one
6-[2-(6-chloroquinolin-2-yl)-1,3-thiazol-4-yl]-n-(2-hydroxyethyl)-3-methanesulfinyl-5-methoxy-1-methyl-4-oxopyridine-2-carboximidic acid
C23H21ClN4O5S2 (532.0641846000001)